000 | 01947 a2200505 4500 | ||
---|---|---|---|
005 | 20250515153552.0 | ||
264 | 0 | _c20090210 | |
008 | 200902s 0 0 eng d | ||
022 | _a1753-4658 | ||
024 | 7 |
_a10.1177/1753465808088902 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKunisaki, Ken M | |
245 | 0 | 0 |
_aExhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. _h[electronic resource] |
260 |
_bTherapeutic advances in respiratory disease _cApr 2008 |
||
300 |
_a55-64 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
650 | 0 | 4 |
_aAndrostadienes _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluticasone |
650 | 0 | 4 |
_aForced Expiratory Volume _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xblood |
650 | 0 | 4 |
_aInterleukin-6 _xblood |
650 | 0 | 4 |
_aInterleukin-8 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
650 | 0 | 4 | _aROC Curve |
650 | 0 | 4 | _aSalmeterol Xinafoate |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSpirometry |
700 | 1 | _aRice, Kathryn L | |
700 | 1 | _aJanoff, Edward N | |
700 | 1 | _aRector, Thomas S | |
700 | 1 | _aNiewoehner, Dennis E | |
773 | 0 |
_tTherapeutic advances in respiratory disease _gvol. 2 _gno. 2 _gp. 55-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1753465808088902 _zAvailable from publisher's website |
999 |
_c18573859 _d18573859 |